3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T31773 | Fenlean | FLZ | |
Fenlean (FLZ) is currently conducting a phase I trial in the Institute of pharmacy, Chinese Academy of medical sciences as a potential treatment for Parkinson's disease. | |||
T30806 | CFLZ-567 | ||
CFLZ-567 is a key intermediate for making carfilzomib. | |||
T21342 | CFLZ-171 TFA salt | ||
CFLZ-171 is a key intermediate for the synthesis of carfilzomib. |